ABSTRACT
The neural dysfunction is triggered by cellular and molecular events that provoke neurotoxicity and neural death. Currently, neurodegenerative diseases are increasingly common, and available treatments are focused on relieving symptoms. Based on the above, in this review we describe the participation of vitexin in the main events involved in the neurotoxicity and cell death process, as well as the use of vitexin as a therapeutic approach to suppress or attenuate neurodegenerative progress. Vitexin contributes to increasing neuroprotective factors and pathways and counteract the targets that induce neurodegeneration, such as redox imbalance, neuroinflammation, abnormal protein aggregation, and reduction of cognitive and/or motor impairment. The results obtained provide substantial evidence to support the scientific exploration of vitexin in these pathologies, since their effects are still little explored for this direction.
Subject(s)
Apigenin/therapeutic use , Neurodegenerative Diseases/drug therapy , Neuroprotective Agents/therapeutic use , Protein Aggregation, Pathological/drug therapy , Animals , Cell Death/drug effects , Humans , Inflammation/drug therapy , Inflammation/metabolism , Inflammation/pathology , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Protein Aggregation, Pathological/metabolism , Protein Aggregation, Pathological/pathologyABSTRACT
Introdução: Avaliou-se a toxicidade aguda de 1,3-diestearil-2-oleil-glicerol (TG1), composto obtido de Platonia insignis Mart. (bacurizeiro), após administração oral em ratos Wistar. Métodos: A toxicidade aguda foi analisada através dos parâmetros hematológicos e bioquímicos. A análise de citotoxicidade in vitro foi feita pelo método do sal 3-(4,5-dimetil-2-tiazol)-2,5-difenil-2-H-brometo de tetrazolium (MTT). Os tecidos cerebrais e hepáticos foram avaliados histopatologicamente. Resultados: O tratamento agudo com TG1(dose de 30 mg kg -1) não produziu alterações hematológicas e histopatológicas nas áreas cerebrais e hepáticas. A redução dos níveis das enzimas transaminase (AST) e fosfatase alcalina (ALKP) pode sugerir proteção hepática. As análises bioquímicas da aspartato aminotransferase, ALKP e do ácido úrico apresentaram seus níveis reduzidos, conferindo preservação dos rins e fígado dos animais (p<0,05). TG1 não revelou potencial citotóxico pelo método MTT. Conclusão: O tratamento com TG1 não produz alterações hematológicas, bioquímicas, histopatológicas cerebrais e hepáticas em ratos o que caracteriza uma baixa toxicidade.
Introduction: The aim of this study was to assess the acute toxicity of 1,3-distearoyl-2-oleoylglycerol (TG1), a compound isolated from Platonia insignis Mart. (bacurizeiro). Methods: The acute toxicity was analyzed by biochemical and hematological parameters. The cytotoxic study was conducted by the MTT method. The histopathological study was conducted in brain and liver tissues. Results: Acute treatment with TG1 (dose of 30 mg. kg -1) did not change the general behavior pattern of rats and not result in hematological and histological changes in the liver. The reduced levels of transaminase and alkaline phosphatase (ALKP) enzymes may suggest even certain liver protection. The biochemical analyzes demonstrated low levels of aspartate aminotransferase, ALKP and uric acid, providing preservation of kidneys and livers of animals (p<0.05). TG1 this study did not reveal cytotoxic potential by MTT method. Conclusion: These results indicate that treatment with TG1 not produce hematological, biochemical and histopathological alterations in rats suggesting low toxicity
